IL111748A0 - Proteins - Google Patents

Proteins

Info

Publication number
IL111748A0
IL111748A0 IL11174894A IL11174894A IL111748A0 IL 111748 A0 IL111748 A0 IL 111748A0 IL 11174894 A IL11174894 A IL 11174894A IL 11174894 A IL11174894 A IL 11174894A IL 111748 A0 IL111748 A0 IL 111748A0
Authority
IL
Israel
Prior art keywords
seq
cdr2
cdr3
chain cdr1
related antigen
Prior art date
Application number
IL11174894A
Other languages
English (en)
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939324819A external-priority patent/GB9324819D0/en
Priority claimed from GB9411089A external-priority patent/GB9411089D0/en
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of IL111748A0 publication Critical patent/IL111748A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11174894A 1993-12-03 1994-11-23 Proteins IL111748A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939324819A GB9324819D0 (en) 1993-12-03 1993-12-03 Proteins
GB9411089A GB9411089D0 (en) 1994-06-03 1994-06-03 Proteins

Publications (1)

Publication Number Publication Date
IL111748A0 true IL111748A0 (en) 1995-01-24

Family

ID=26303960

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11174894A IL111748A0 (en) 1993-12-03 1994-11-23 Proteins

Country Status (14)

Country Link
US (1) US5665357A (xx)
EP (1) EP0731838B1 (xx)
JP (1) JP3962087B2 (xx)
AT (1) ATE259877T1 (xx)
AU (1) AU684863B2 (xx)
CA (1) CA2174972A1 (xx)
DE (1) DE69433563T2 (xx)
DK (1) DK0731838T3 (xx)
ES (1) ES2214494T3 (xx)
GB (1) GB9424108D0 (xx)
IL (1) IL111748A0 (xx)
NZ (1) NZ276745A (xx)
PT (1) PT731838E (xx)
WO (1) WO1995015382A1 (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040117863A1 (en) * 1998-09-18 2004-06-17 Edge Michael D. Transgenically produced fusion proteins
RU2002110121A (ru) * 1999-09-17 2004-03-10 Джитиси Байотерапьютикс, Инк. (Us) Слитые белки, полученные трансгенным способом
BR0014524A (pt) * 1999-09-17 2002-06-11 Genzyme Transgenics Corp Proteìnas de fusão otimizadas com subunidade
WO2003074704A1 (fr) * 2002-03-01 2003-09-12 Japan Envirochemicals, Ltd. Proteines capables de se lier aux hormones sexuelles feminines et procede de preparation
CR20120384A (es) * 2003-05-14 2016-12-02 Immunogen Inc Composición de farmaco conjugado
US20110166319A1 (en) * 2005-02-11 2011-07-07 Immunogen, Inc. Process for preparing purified drug conjugates
EP2468304A3 (en) 2005-02-11 2012-09-26 ImmunoGen, Inc. Process for preparing stable drug conjugates
NZ599176A (en) * 2005-08-03 2014-04-30 Immunogen Inc Immunoconjugate formulations
SI1928503T1 (sl) 2005-08-24 2012-11-30 Immunogen Inc Postopek za pripravo konjugatov majtansinoid protitelo
KR101764081B1 (ko) 2008-04-30 2017-08-01 이뮤노젠 아이엔씨 가교제 및 그 용도
US8293100B2 (en) 2009-03-13 2012-10-23 Terrasep, Llc Methods and apparatus for centrifugal liquid chromatography
TR201907573T4 (tr) 2009-06-03 2019-06-21 Immunogen Inc Konjugasyon yöntemleri̇
EP2473530B1 (en) * 2009-09-03 2015-04-22 Vancouver Biotech Ltd. Monoclonal antibodies against gonadotropin-releasing hormone receptor
IN2012DN02780A (xx) 2009-10-06 2015-09-18 Immunogen Inc
WO2012135517A2 (en) 2011-03-29 2012-10-04 Immunogen, Inc. Preparation of maytansinoid antibody conjugates by a one-step process
KR20220009505A (ko) 2011-03-29 2022-01-24 이뮤노젠 아이엔씨 일-단계 방법에 의한 메이탄시노이드 항체 접합체의 제조
US10035817B2 (en) 2012-10-04 2018-07-31 Immunogen, Inc. Method of purifying cell-binding agent-cytotoxic agent conjugates with a PVDF membrane
JP2016021883A (ja) * 2014-07-17 2016-02-08 日産化学工業株式会社 ヒト大腸癌細胞Ｃｏｌｏ２０５に特異的に結合する核酸
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
MA40934A (fr) 2014-11-19 2017-09-27 Immunogen Inc Procédé de préparation de conjugués agent de liaison cellulaire-agent cytotoxique
KR20180105233A (ko) 2016-02-05 2018-09-27 이뮤노젠 아이엔씨 세포 결합제-세포독성제 접합체를 제조하기 위한 효율적인 방법
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
WO2021127007A1 (en) * 2019-12-16 2021-06-24 Bluebird Bio, Inc. Anti-bcma car antibodies, conjugates, and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
EP0289400A3 (en) * 1987-04-30 1990-01-24 Fairchild Weston Systems Inc. High speed asynchronous data multiplexer/demultiplexer
HUT53672A (en) * 1988-02-25 1990-11-28 Gen Hospital Corp Quick immunoselective cloning process

Also Published As

Publication number Publication date
ES2214494T3 (es) 2004-09-16
AU1113095A (en) 1995-06-19
US5665357A (en) 1997-09-09
DE69433563D1 (de) 2004-03-25
GB9424108D0 (en) 1995-01-18
JPH09506507A (ja) 1997-06-30
DK0731838T3 (da) 2004-05-24
ATE259877T1 (de) 2004-03-15
PT731838E (pt) 2004-05-31
EP0731838A1 (en) 1996-09-18
JP3962087B2 (ja) 2007-08-22
EP0731838B1 (en) 2004-02-18
NZ276745A (en) 1998-02-26
CA2174972A1 (en) 1995-06-08
AU684863B2 (en) 1998-01-08
DE69433563T2 (de) 2004-12-23
WO1995015382A1 (en) 1995-06-08

Similar Documents

Publication Publication Date Title
GB9424108D0 (en) Proteins
NZ614727A (en) Human antibodies that bind human tnfa
RS51373B (sr) Antitela za insulinu sličan faktor rasta i receptor
HUP0104604A2 (hu) CTLA-4 elleni humán monoklonális ellenanyagok
NZ593068A (en) IL-18 antibody
NZ547157A (en) Interferon Alpha Antibodies and their uses
NZ611387A (en) Selected antibodies binding to anionic phospholipids and aminophospholipids and their use in treatment
RS52484B (en) CD40 ANTIBODIES
AU1273695A (en) Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
WO1998050433A3 (en) Human monoclonal antibodies to epidermal growth factor receptor
CA2006865A1 (en) Humanized immunoglobulins and their production and use
NZ529571A (en) Human antibodies that bind human IL-12 and methods for producing
RS51829B (sr) Ljudska antitela specifična za interleukin 15 (il-15)
AU638535B2 (en) Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")
RU2012102323A (ru) Способ лечения ревматоидного артрита посредством лекарственного препарата на основе выделенного человеческого антитела или его антигенсвязывающего фрагмента
AU3933695A (en) Humanized antibodies to CD38
CA2103059A1 (en) Method for making humanized antibodies
SG151284A1 (en) Antibodies against ccr5 and uses thereof
IL136544A0 (en) Humanization of murine antibody
WO1999003987A3 (fr) Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
CA2105979A1 (en) Monoclonal antibody against lps core
SE9600434L (sv) Fusionsprotein, bakteriofag uttryckande proteinet, dessas användning samt hybridoma celler och monoklonaler producerade av cellerna